Acute Dysnatremias - a dangerous and overlooked clinical problem

Scand J Trauma Resusc Emerg Med. 2019 May 28;27(1):58. doi: 10.1186/s13049-019-0633-3.

Abstract

Background: Dysnatremias are common electrolyte disturbances with significant morbidity and mortality. In chronic dysnatremias a slow correction rate (<10 mmol/L/24 h) is indicated to avoid neurological complications. In acute dysnatremias (occurring <48 h) a rapid correction rate may be indicated. Most guidelines do not differ between acute and chronic dysnatremias. In this review, we focus on the evidence-based treatment of acute dysnatremias.

Methods: A literary search in PubMed and Embase. A total of 72 articles containing 79 cases were included, of which 12 cases were excluded due to lack of information.

Results: Of 67 patients (70% women) with acute dysnatremia, 60 had hypo- and 7 had hypernatremia. All patients with hyper- and 88% with hyponatremia had a rapid correction rate (> 10 mmol/L/24 h). The median time of correction was 1 day in patients with hypo- and 2.5 days in patients with hypernatremia. The mortality was 7% in patients with hypo- and 29% in patients with hypernatremia.

Interpretation: Severe acute dysnatremias have significant mortality and require immediate treatment. A rapid correction rate may be lifesaving and is not associated with neurological complications. Chronic dysnatremias, on the other hand, are often compensated and thus less severe. In these cases a rapid correction rate may lead to severe cerebral complications.

Keywords: Acute dysnatremia; Ecstasy-associated hyponatremia; Exercise-associated hyponatremia; Hypernatremia; Hyponatremia; Psychogenic polydipsia; Salt intoxication; Water intoxication.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Female
  • Hospitalization
  • Humans
  • Hypernatremia / epidemiology
  • Hypernatremia / mortality
  • Hypernatremia / physiopathology*
  • Hyponatremia / epidemiology
  • Hyponatremia / mortality
  • Hyponatremia / physiopathology*
  • Male
  • Middle Aged
  • Nervous System Diseases
  • Respiration, Artificial / adverse effects
  • Young Adult